XML 16 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Apr. 01, 2017
Apr. 02, 2016
Operating activities:    
Net income $ 2,676,367 $ 1,900,501
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 524,810 586,422
Provision for losses on accounts receivable 22,492
Loss on disposal of equipment 1,569 7,658
Increase in cash value of life insurance (72,383) (79,715)
Deferred compensation (45,941) (42,769)
Gain on life insurance proceeds (731,623)
Changes in operating assets and liabilities:    
Accounts receivable 600,057 1,342,115
Inventories 32,164 1,024,721
Prepaid expenses and other assets (294,377) (237,074)
Accounts payable and accrued expenses (1,254,613) (2,591,084)
Net cash provided by operating activities 1,458,522 1,910,775
Investing activities:    
Purchases of property and equipment (317,495) (275,384)
Insurance proceeds 3,353,851
Payments for other assets (69,483) (57,067)
Net cash provided by (used for) investing activities 2,966,873 (332,451)
Financing activities:    
Dividends paid (881,800) (873,590)
Proceeds of revolving credit line 2,900,000
Repayment of revolving credit line (2,900,000)
Purchase and retirement of common stock (209,880)
Net cash used for financing activities (881,800) (1,083,470)
Effect of exchange rates on cash (22,849) 14,500
Increase in cash and cash equivalents 3,520,746 509,354
Cash and cash equivalents at beginning of period 3,752,945 [1] 1,224,026
Cash and cash equivalents at end of period $ 7,273,691 $ 1,733,380
[1] The Balance Sheet at October 1, 2016, has been derived from the audited financial statements at that date.